Ever Source Wealth Advisors, LLC Edgewise Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 18 shares of EWTX stock, worth $475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$475% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$396 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$235 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$162 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$159 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$132 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.67B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...